- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Astellas Pharma Korea, Inc.
Total 1240 results
-
Astellas Pharma Global Development, Inc.CompletedAcute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) / Internal Tandem Duplication (ITD) MutationTaiwan, Poland, Serbia, United States, Brazil, Canada, Czechia, Denmark, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Portugal, Romania, Spain, Sweden, United Kingdom
-
Astellas Pharma Global Development, Inc.CompletedHot FlashesUnited States, Czechia, Canada, Latvia, Poland, Spain, Ukraine, United Kingdom
-
Astellas Pharma Global Development, Inc.CompletedHot FlashesUnited States, Canada, Czechia, United Kingdom, Latvia, Poland, Spain
-
Astellas Pharma Global Development, Inc.CompletedHealthy Volunteers | Hepatic ImpairmentUnited States
-
Astellas Pharma Global Development, Inc.CompletedCytomegalovirus (CMV)-Positive Recipients | Allogeneic, Hematopoietic Cell Transplant (HCT)Japan, Korea, Republic of, United States, Canada, Australia, Belgium, France, Germany, Spain, Sweden, Taiwan
-
Astellas Pharma Global Development, Inc.CompletedAcute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) MutationUnited States
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Global Development, Inc.CompletedMetastatic Renal Cell CarcinomaUnited States, Canada
-
Astellas Pharma Global Development, Inc.Approved for marketingAcute Myeloid Leukemia (AML) | FMS-like Tyrosine Kinase-3 (FLT3) MutationsUnited States, Canada, Japan
-
Astellas Pharma Global Development, Inc.CompletedFibromyalgiaUnited States
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Global Development, Inc.CompletedRelapsed Lymphoid Malignancy | Refractory Lymphoid MalignancyUnited States, Canada
-
Astellas Pharma Global Development, Inc.CompletedHealthy VolunteersUnited States
-
Astellas Pharma Global Development, Inc.CompletedOveractive Bladder (OAB)United States, Canada
-
Astellas Pharma Global Development, Inc.CompletedNon-Small-Cell Lung Cancer (NSCLC) | Epidermal Growth Factor Receptor MutationsUnited States
-
Astellas Pharma Global Development, Inc.CompletedCLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction | CLDN18.2-positive Adenocarcinoma of Esophagus | CLDN18.2-positive Gastric AdenocarcinomaGermany, Latvia
-
Astellas Pharma Global Development, Inc.WithdrawnHealthy Volunteers
-
Astellas Pharma Global Development, Inc.CompletedRheumatoid Arthritis (RA)United States, Poland
-
Astellas Pharma Global Development, Inc.CompletedLymphoma | Advanced Cancer | Refractory Solid TumorsUnited States
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Global Development, Inc.CompletedRheumatoid ArthritisMoldova, Republic of
-
Astellas Pharma Global Development, Inc.CompletedAdvanced Solid Tumors | Pharmacokinetics of 14C-OSI-906United States
-
Astellas Pharma IncAstellas Pharma Global Development, Inc.CompletedSolid TumorsUnited States, Japan, Korea, Republic of, Taiwan
-
Astellas Pharma Global Development, Inc.No longer availableAcute Myeloid Leukemia (AML) | FMS-like Tyrosine Kinase-3 (FLT3) MutationsAustralia, Italy, United Kingdom
-
Astellas Pharma Global Development, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC) | Epidermal Growth Factor Receptor (EGFR) MutationsUnited States
-
Astellas Pharma Global Development, Inc.CompletedHealthy Volunteers | Pharmacokinetics of ASP1941United States
-
Astellas Pharma IncRecruiting
-
Astellas Pharma IncRecruiting
-
Astellas Pharma IncActive, not recruitingAcute Myeloid Leukemia | FLT3-mutated Acute Myeloid LeukemiaJapan, Korea, Republic of, Taiwan
-
Astellas Pharma IncActive, not recruitingProgressive Metastatic Prostate CancerChina, Hong Kong, Korea, Republic of, Taiwan
-
Astellas Pharma IncCompletedMetastatic Castration Resistant Prostate CancerIndia
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedDe Novo Kidney Transplant PatientsChina
-
Astellas Pharma IncCompletedBenign Prostate HyperplasiaJapan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedAnemia in Chronic Kidney Disease Patients Not on DialysisJapan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedDepression | Bipolar DisorderJapan
-
Astellas Pharma IncCompletedRheumatoid ArthritisJapan, Korea, Republic of, Taiwan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedAnemia | Hemodialysis | Renal ImpairmentJapan
-
Astellas Pharma IncCompletedHealthy Volunteer | Pharmacokinetics of ASP015KJapan
-
Astellas Pharma IncCompletedMajor Depressive DisorderJapan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedRheumatoid ArthritisUnited States
-
Astellas Pharma IncCompletedDiabetes Mellitus, Type 2United States, India, Philippines, Colombia, Mexico
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan